Old MRP ₹105
MRP ₹98.44
₹78.75
₹9.84/Units
100% genuine medicines
Safe & secure payments
15 days Easy returns
Prescription required for this medicine
Store Below 30o C
CompositionVildapride-50 Tablet is used to manage type 2 diabetes mellitus. This medication is a dipeptidyl peptidase-4 (DPP-4) inhibitor that contains vildagliptin. It works by inhibiting the breakdown of incretin hormones, thereby stimulating the pancreas to produce more insulin when blood sugar levels are high. It is often used in combination with other diabetes medications to achieve better blood sugar control.
Vildapride-50 Tablet is used for the management of type 2 diabetes in adults, working as a DPP-4 inhibitor to assist with blood sugar control by enhancing the body's natural release of insulin, thereby reducing the risk of severe, long-term diabetes-related complications when used as an adjunct to diet, exercise, or other diabetes medications.
Here's how you should take Vildapride-50 Tablet:
Swallow the tablet whole with a glass of water.
Do not crush or chew the tablet before swallowing.
You can take this medicine with or without food.
For specific dosage advice tailored to your health condition, please consult your doctor.
Vildapride-50 Tablet is taken orally.
Common side effects of Vildapride-50 Tablet include upper respiratory tract infections (nasopharyngitis), headache, dizziness, and hypoglycemia.
Most side effects are temporary and generally harmless, which resolve upon discontinuing the use of Vildapride-50 Tablet. However, if you experience any serious side effects or worsening of any of the symptoms, please consult your doctor. Here are a couple of tips for managing some common side effects:
Upper respiratory tract infections: If you develop a cough or cold symptoms, ensure to stay hydrated and rest well.
Hypoglycaemia: Try taking Vildapride-50 Tablet with your meal to help manage this.
Vildapride-50 Tablet contains vildagliptin (50 mg), which influences the body as follows:
DPP-4 Enzyme Inhibition: Vildagliptin works by blocking an enzyme known as dipeptidyl peptidase-4 (DPP-4). This particular enzyme is responsible for breaking down certain hormones called incretins that stimulate insulin production in the pancreas.
Enhances Incretin Effects: By preventing the breakdown of incretins like GLP-1 and GIP, vildagliptin effectively enhances their effects. This leads to an increase in insulin secretion from pancreatic beta cells in response to high blood glucose levels and reduces the release of glucagon from pancreatic alpha cells.
This dual action helps regulate blood sugar levels more effectively, thus helping to manage type 2 diabetes.
If you are pregnant, it's advised to be cautious while taking Vildapride-50 Tablet. Always consult your doctor before starting this medication.
It's best to discuss with your doctor the risks and benefits of taking this medication while breastfeeding.
It's always wise to consult your doctor about drinking alcohol while taking this medicine as it may increase the risk of side effects.
Vildapride-50 Tablet should be used with caution if you have liver problems. It is not recommended for severe liver diseases. Make sure to discuss your liver health with your doctor before starting this medication.
If you have any kidney issues, it's advised to use Vildapride-50 Tablet with caution. Please consult your doctor for further guidance.
Vildapride-50 Tablet is not known to impact your ability to drive or operate machinery. If you feel dizzy or experience any side effects that might affect your ability to concentrate, avoid driving or operating machines, and speak to your doctor.
If you are allergic to vildagliptin or any other components of Vildapride-50 Tablet, avoid using this medicine. Make sure to inform your doctor about any known allergies before starting the medication.
Vildapride-50 Tablet is not recommended for use in children under 18 years of age. Always consult a doctor before giving any medication to a child.
As older patients might be more susceptible to side effects and have kidney issues, it’s advised that they take Vildapride-50 Tablet under medical supervision. If you are above 70 years of age, you should discuss your overall health status with your doctor before starting this medication.
Vildapride-50 Tablet interacts with the following medicines:
CYP3A4/5 inhibitors: Vildapride-50 Tablet's active ingredient, vildagliptin, may have increased exposure when co-administered with strong inhibitors like ketoconazole, which could require a dose adjustment.
Sulfonylureas and insulin: When used together with Vildapride-50 Tablet, these medicines might enhance the hypoglycaemic effect of vildagliptin, potentially leading to low blood sugar. Medicines like glimepiride or insulin might need a dose adjustment to reduce this risk.
There are no known interactions between Vildapride-50 Tablet and any specific foods or beverages.
Vildapride-50 Tablet interacts with the following diseases:
Pancreatitis: If you have a history of pancreatitis, you should use Vildapride-50 Tablet with caution as it might exacerbate your condition.
Galactose intolerance/severe lactase deficiency/glucose-galactose malabsorption: Due to the presence of lactose in the tablet formulation, people with these conditions should avoid using Vildapride-50 Tablet.
The daily dose of Vildapride-50 Tablet should be taken exactly as your doctor prescribes. The dosage will vary depending on factors like your response to treatment and the severity of your condition. Remember, it's crucial not to exceed the recommended dosage without seeking advice from your doctor.
Taking more than the prescribed dose of Vildapride-50 Tablet may lead to symptoms like dizziness and headaches. If you've accidentally taken too much of this medicine, don't panic. Do inform your doctor about it so they can provide appropriate advice.
In case you've missed a dose of Vildapride-50 Tablet, take it as soon as you remember. But if it's nearly time for the next dose, skip the missed one and continue with your regular dosing schedule. It's important not to take an extra dose to make up for a missed one, unless advised by your doctor.
Keep your Vildapride-50 Tablet in a cool, dry place.
The ideal storage temperature is 20°C to 25°C.
Avoid exposure to direct sunlight and moisture.
To maintain safety, keep this medicine out of the reach of children.
Always check the expiry date before use.
As Vildapride-50 Tablet is used to manage type 2 diabetes, a regular exercise routine can help control blood sugar levels and improve overall health.
Consuming a balanced diet, low in sugar and high in fibre, can support the effectiveness of this medication by managing blood sugar levels.
| Available Dosage Types | Tablet |
| Habit Forming | No |
| Ailment | Type 2 diabetes |
| Drug Category | DPP-4 Inhibitor |
| Therapeutic Category | Antidiabetic |
Vildapride-50 Tablet is an oral medication used to manage type 2 diabetes in adults, alongside dietary changes and exercise.
It contains vildagliptin which inhibits an enzyme called DPP-4, thereby helping to regulate your blood sugar levels effectively.
Yes, Vildapride-50 Tablet can be taken with other diabetes medicines such as metformin, sulfonylureas, or insulin, but under your doctor's supervision.
Common side effects can include upper respiratory tract infections, headaches, and dizziness. Rarely, it may cause serious side effects like pancreatitis.
You should monitor your renal function periodically as dose adjustment may be required for renal impairment. It's not recommended for severe liver insufficiency.
The use of Vildapride-50 Tablet in pregnancy is only advised if the potential benefit outweighs the potential risk. Always consult your doctor first.
Store your tablets at room temperature between 20°C to 25°C (68°F to 77°F), protect from moisture, and keep out of reach of children.
Check out Editorial Policy
NVR & FB. (2020). Galvus. In Galvus (pp. 1–19). https://www.novartis.com/sg-en/sites/novartis_sg/files/Galvus-Jul2020.SIN-App051120.pdf
Vildagliptin: Uses, interactions, mechanism of action | DrugBank Online. (n.d.). DrugBank. https://go.drugbank.com/drugs/DB04876
Mathieu, C., Kozlovski, P., Paldánius, P. M., Foley, J. E., Modgill, V., Evans, M., & Serban, C. (2017). Clinical Safety and Tolerability of Vildagliptin – Insights from Randomised Trials, Observational Studies and Post-marketing Surveillance. European Endocrinology, 13(02), 68. https://doi.org/10.17925/ee.2017.13.02.68
We, at Truemeds make a diligent attempt to deliver accurate, expert- drafted and thoroughly reviewed medicine related information to our consumers. However, it should, by no means, be considered a substitute for prescription from a certified doctor or a trustworthy doctor-patient relationship. In fact we detest any form of self medication without expert advice. The sole purpose of the information on our portal is to educate our consumers, which helps improve the communication between a doctor and a patient. The information by no means is complete in its entirety and should not be used to diagnose or treat any medical condition. No amount of information can replace the experience and expertise of a doctor, therefore his/her advice always holds priority and should be followed appropriately.
50.1% CHEAPER
9259 users bought this instead
...View more
...View more
...View more
Company
About UsHealth ArticleHealth StoriesHealth LibraryDiseases & Health ConditionsAyurvedaUnderstanding Generic MedicinesAll MedicinesAll BrandsNeed HelpFAQSecuritySavings CalculatorSubscribe
Registered Office Address
Grievance Officer
Download Truemeds
Contact Us
Our customer representative team is available 7 days a week from 9 am - 9 pm.
v4.14.0
2026 - Truemeds | All rights reserved. Our content is for informational purposes only. See additional information.
Our Payment Partners
